Carlsmed, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Carlsmed, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-38.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 67% of Healthcare companies in United States.
Cash Cushion Ratio
+23%Cash, after subtracting all debt, equals 23% of its market value (net cash).
Higher than 65% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Carlsmed, Inc. made a loss over the last year. Carlsmed, Inc. owes $0.29 for every $1 it owns. Carlsmed, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCarlsmed, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.73The share price is 4.73 times Carlsmed, Inc.'s book value per share, higher than 70% of Healthcare companies in United States.
Market cap
$399 MThe total market value of all of Carlsmed, Inc.'s shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$84 MWhat Carlsmed, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.09Net worth divided by the number of shares. The share price of $14.61 is 4.7 times this, which is the P/B above.
Return on equity (ROE)
-66.1%Carlsmed, Inc. lost 66.1% of its shareholders' money over the last year, lower than 60% of Healthcare companies in United States.
Owes vs Owns
0.29×Carlsmed, Inc. owes $0.29 for every $1 it owns (low), lower than 61% of Healthcare companies in United States.
Dividend yield
NoneCarlsmed, Inc. does not currently pay a dividend.
Revenue growth
+86%Revenue rose 86% in the year to Dec 2025.
Profit growth
LossCarlsmed, Inc. made a loss in each of the last two years.
Profit margin
-58.7%Carlsmed, Inc. lost $59 for every $100 of revenue.
Interest cover
Not coveredCarlsmed, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashCarlsmed, Inc. held $92 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Carlsmed, Inc.: $399 M ÷ $84 M (30 Jun 2026) = 4.7.
What is Carlsmed, Inc.'s return on equity?
Carlsmed, Inc. lost 66.1% of its shareholders' money over the last year, lower than 60% of Healthcare companies in United States.
How much does Carlsmed, Inc. owe compared with what it owns?
Carlsmed, Inc. owes $0.29 for every $1 it owns (low), lower than 61% of Healthcare companies in United States.
Does Carlsmed, Inc. pay a dividend?
No. Carlsmed, Inc. does not currently pay a dividend.
Is Carlsmed, Inc.'s revenue growing?
Revenue rose 86% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.